search
Back to results

Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition

Primary Purpose

Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Enfamil HM fortifier, Mead Johnson
Enfalac Premature Formula, Mead Johnson Nutritionals
Mothers own milk
Sponsored by
University of Southern Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infant, Very Low Birth Weight focused on measuring very preterm, nutrition, 6 year follow-up, growth, metabolic syndrome, allergy, dexa

Eligibility Criteria

6 Years - 8 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participated in the original study when they were discharge from hospital
  • Parents accept of participation in the 6 year follow-up

Exclusion Criteria:

  • Participation not accepted by parents
  • Genetic diseases with influence on growth

Sites / Locations

  • HC Anderson Children´s Hospital, OUH

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Group 1, HM

Group 2, HMF

Group 3, PF

Arm Description

This group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk.

This group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson.

This group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals

Outcomes

Primary Outcome Measures

Growth
Measurement of weight at 6 years corrected age

Secondary Outcome Measures

Metabolic syndrome
Dexa scan including fat mass, muscle mass, bone mass and Body Mass Index.

Full Information

First Posted
February 28, 2014
Last Updated
October 26, 2016
Sponsor
University of Southern Denmark
Collaborators
Aarhus University Hospital, Holbaek Sygehus, Kolding Sygehus
search

1. Study Identification

Unique Protocol Identification Number
NCT02078687
Brief Title
Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition
Official Title
Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Nutrition in the First Four Month After Hospital Discharge
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern Denmark
Collaborators
Aarhus University Hospital, Holbaek Sygehus, Kolding Sygehus

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a follow-up cohort study of 6 years old children born preterm in Denmark from 2004-2008, and at four different neonatal units. During hospitalisation they received breast milk with fortification. At time of discharge there were made 3 different nutrition groups; if possible they were randomised into one of two groups: Breastfeeding solely Breastfeeding with fortification If breastfeeding was not possible they were put in group 3 and were bottle fed with: Preterm formula This nutrition intervention went on for 4 month. At the age of 6, the children will be invited to come for an ambulant control and other examinations regarding growth, allergy and metabolic syndrome.
Detailed Description
Project background: The study is based on a follow-up of a cohort of very preterm infants born before week 32, as at discharge from the neonatal departments were randomized to a protein supplement or not while breastfeeding after discharge. If the preterm child was not breastfed, it received a premature infant formula after discharge. Since we have three groups of prematures, which are fed differently after discharge, it is useful to follow up at 6 years of age and specifically examine the following areas: Metabolic syndrome: Unlike the past, the survival rate of very preterm infants is now high. Most is expected to survive. The question is the extent to which these children have increased morbidity compared with children born at term, and their quality of life is affected by the fact that they are born prematurely. There has previously been shown a link between children born SGA and later development of type 2 diabetes mellitus, hypertension, ischemic heart disease and cerebrovascular disasters. Too rapid catch-up growth also increases the possible risk of developing metabolic syndrome in the mature child. The question is whether this is also the case in children born prematurely and whether the risk is the same. The problem is just that you want to provide them with adequate amino acids for protein synthesis, as they approach the growth of peers fetuses and also ensure the development of the brain with essential fatty acids, but maybe they can not tolerate a too rapid "catch-up" - growth. A study comparing preterm born children aged 4-10 years with mature children born of the same age found that the group with preterm births had increased systolic and diastolic blood pressure and higher insulin levels. This was true regardless of whether the children were born SGA and AGA at birth. This concluded that there were metabolic abnormalities in preterm similar to those found in children born at term but SGA. The same article mentions the concept of "fetal programming". This covers a hypothesis which suggests that a fetus at risk in the uterus will adapt best to survive, and this adjustment will be permanent. The same team has published an article, which have found impaired insulin sensitivity in preterm infants (SGA and AGA) compared to mature AGA children. Insulin sensitivity is greatest in the mature AGA. Next comes the mature SGA and eventually the premature. To show the importance of this area, they point out that out of those who have diabetes mellitus type 2, 35% has had low birth weight. In trying to find a way it will be interesting, and very relevant, to see if diet the first months of life have an impact on these metabolic complications later in life. Allergy: It is unknown whether preterms are at increased risk of developing allergic symptoms. Breastfeeding reduces the risk of developing allergic diseases, while cow milk-based infant formulas increase the risk. The preterm infants in this study completed during hospitalization with fortifier containing cow's milk protein, and the preterm infant formula is cow milk based. It is therefore interesting to see if there is an increased incidence of allergic symptoms in one of the groups. An article formed on the basis of a study of two groups of children, one group consisted of children with a birth weight less than 1500 g, and the second group consisted of children with a birth weight over 2500 g, describes that there was no difference in the incidence of atopy. Another study studied the incidence of food allergies in an area of 13,980 children, and found that 4.23 % were diagnosed with this at the age of six. There was no difference in the incidence of categorization in GA. The first study mentioned above studied also the appearance of wheezing. This was done using spirometry. The result was that the lifetime risk of preterm births was 43% for developing wheezing, while it was only 17% in mature births. Besides wheezing low GA at birth was associated with decreased lung capacity, reduced forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) and asthma. A relevant question is whether children develop these respiratory symptoms solely on the basis that they are born preterm or nutritional type influences the risk of its development. Growth and catch-up: Some studies have gradually studied prematurely born children's growth compared to some control children - especially in the first period after discharge from the neonatal units. As we know, human milk has the best composition in relation to children's needs. There has been made a study on nutrition of preterms with human milk against fortified human milk which states that those who get pure milk, are at greatest risk of malnutrition by discharge and that it is a good strategy to provide breast milk multinutrient enrichment. In the study mothers milked out half of their daily quantity for enrichment. Though, they request long-term studies to determine the long-term effects of it. Other studies have followed prematurely born children up to 20 years of age and 11 years of age and were compared with a control group of normal weight, not preterm births. Outcome was height, weight, BMI. In one case also head circumference. One study concludes that all very low birthweight children (VLBW) were smaller than the control group. In particular SGA boys were smaller. The second study concluded that extremely immature children have poor growth in early childhood, but they have catch-up until 11 years of age. All prematures remain less than the control group. A comparison of both nutrition after discharge and follow-up beyond 1 year of age will be very interesting to be able to optimize nutrition and growth of extremely premature infants, both AGA and SGA. A dual-energy X-ray absorptiometry (DEXA) scan is a study that reveals body composition of bone, muscle and fat. A study of whether the scanning can be used to detect body composition, concluded that DEXA is a good tool for this. It is a quick (minutes) survey that provides minimal radiation, and it is interesting because a scan of the 3 groups in this project will elucidate whether there is a difference in body composition and thus whether a nutritional type provides better basis for the best growth. The same study, which was built on an RCT (randomized controlled trial) of 33 children with GA less than 35 weeks and a birth weight below 1,750 grams who received either 1) standard replacement or 2) enriched compensation for 2 months after discharge, found no difference in body composition or weight gain. It calls for larger studies with longer follow-up. Another study, just as this PhD project, divide the children into several groups depending on Nutrition (1: enriched substitute 2: standard replacement 3: human breast milk), found by DEXA scanning at 6 months of age, group 1 had lower fat mass and group 3 had lower lean (muscle) mass and higher fat mass. So, there is a difference in body composition depending on nutrition. It may sound logical, but will it affect children later in life? - and if so, in what way? From the above examples of previous studies, one can conclude that the optimal nutrition of preterms is under development and there is a continued lack of clarification of how preterm infants grow after discharge and whether one type of nutrition is better. Hypotheses: Nutrition after discharge does affect premature children's growth in the first years of life. Catch-up growth proceeds after 1 year of age. The growth pattern for prematures born SGA is different from prematures born AGA. There is no increase in allergies between prematures, who was fed with premature formula or enriched mothers milk before and after discharge compared with mothers milk without enrichment. Premature children fed with a preterm formula have an extended risk for developing metabolic syndrome on basis of excessive growth the first months of life. It is possible that premature SGA children have greater risks of developing metabolic syndrome on the basis of excessive growth the first month of life. Fat mass and lean mass vary among prematures depending on the nutrition the first month after discharge. Purpose of the project: Investigate whether there are long-term effect on growth after cessation of enrichment of breast milk in 2, 3 and 6 years of age. Examine the relationship between protein intake to 4 months of age (corrected) and blood pressure, HbA1c and serum cholesterol by 6 years of age. Uncover the incidence of allergy symptoms from the eyes and nose, skin, stomach / intestinal and respiratory tract incl affected lung function in children born prematurely. Elucidate whether there is an increased risk of metabolic syndrome in children born prematurely and nourished in different ways. Investigate whether preterms have different fat distribution and nutrition up to 4 months corrected age affect them. Illuminate catch-up growth in children born prematurely and up to 6 years of age. Planned studies: Weight, height, head circumference, blood pressure Registration of any allergy symptoms and airway symptoms. Blood tests for diabetes, screening for metabolic syndrome and allergies. Questionaires to investigate allergy symptoms. A dexa scan to see the body composition of fat, muscle and bone. Randomization: The children were randomized when they could eat (breast or bottle) at gestational age 34-42. Twins and triplets were randomly assigned to the same group. At randomization an impartial person in the department the child was hospitalized in, pulled an envelope with information on what kind of nutrition, the child should have after discharge and up to 4 months of corrected age. Statistics: Originally, there were strength calculations prior to randomization in the project. This showed that there were needed 85 children in each feeding group. A total of 320 children in the original project were enrolled. However, there has been a waiver until 1 year of age, and there are 278 children remaining to follow-up. Wilcoxon rank-sum test or t-test for continuous variables, and if categorical variables chi2test will be used to compare the nutritional groups. Multiple logistic regression models will be used to compare the clinical relevant variables that have possible influence on the growth of various dietary groups. Growth will be analyzed from Z-score and delta z-score and will be calculated from a relevant reference for comparing nutritional groups growth. Allergy risks and metabolic syndrome will be calculated using the above methods and odds ratio. Project Period: From 2004 - 2008 there were formed three groups of preterm children at clinical randomization. A Ph.D. dissertation was made subsequently dealing with preterm growth up to 1 year of age, nutrition and composition of breast milk of mothers of preterm babies. Between the ages of 2 and 3 years, children have come to control for a follow-up Ph.D. The children become 6 years from July 2010 - 2014, where they also will be invited to a follow-up check on the current Ph.D. project. The children will be followed up in their respective departments / hospitals in Kolding, Skejby, Holbæk and Odense. Ethical considerations: For inclusion in the randomized controlled study parents signed an acceptance which included follow-up at 6 years of age. The initial randomized controlled study was approved by the Ethics Committee 1 July 2004 (J. Nr.VF20030208). As part of the 6-year follow-up, there is added and approved Protocol 1-8. In addition, permission from the Data Inspectorate of the original project with change in 2007 (J. No 2007-41-1349) is extended until 2016.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy, Dietary Modification
Keywords
very preterm, nutrition, 6 year follow-up, growth, metabolic syndrome, allergy, dexa

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
239 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1, HM
Arm Type
Active Comparator
Arm Description
This group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk.
Arm Title
Group 2, HMF
Arm Type
Active Comparator
Arm Description
This group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson.
Arm Title
Group 3, PF
Arm Type
Active Comparator
Arm Description
This group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals
Intervention Type
Dietary Supplement
Intervention Name(s)
Enfamil HM fortifier, Mead Johnson
Other Intervention Name(s)
Enfamil HM fortifier, Mead Johnson, Njimegen, Netherlands
Intervention Description
Enfamil was added to a small amount of mothers expressed milk and given in a bottle or with a small cup every day. Group 2 (HMF) received 5 packets each day for 4 month containing; 17.5 kcal, 1.375 g protein/ 5 packets
Intervention Type
Dietary Supplement
Intervention Name(s)
Enfalac Premature Formula, Mead Johnson Nutritionals
Other Intervention Name(s)
Enfalac PF, Mead Johnson Nutritionals, Njimegen, Netherlands
Intervention Description
Group 3 received Enfalac containing: 68 kcal, 2 g protein, 7.4 g carbohydrate, 3.5 g fat/ 100 ml
Intervention Type
Dietary Supplement
Intervention Name(s)
Mothers own milk
Intervention Description
Group 1 received mothers own milk without fortification
Primary Outcome Measure Information:
Title
Growth
Description
Measurement of weight at 6 years corrected age
Time Frame
Follow-up at approximately 6 years corrected age
Secondary Outcome Measure Information:
Title
Metabolic syndrome
Description
Dexa scan including fat mass, muscle mass, bone mass and Body Mass Index.
Time Frame
Follow-up at approximately 6 years corrected age
Other Pre-specified Outcome Measures:
Title
Allergy
Description
Test for lung function: body box breathing test
Time Frame
Follow-up at approximately 6 years corrected age
Title
Growth
Description
Lenght at 6 years corrected age
Time Frame
Follow-up at approximately 6 years corrected age
Title
Growth
Description
Head circumference at 6 years corrected age
Time Frame
Follow-up at approximately 6 years corrected age
Title
Metabolic syndrome
Description
Blood test; blood glucose, HbA1c, HDL, insulin, Insulin-like growth factor 1 (IgF1), C-peptide
Time Frame
Follow-up at approximately 6 years corrected age
Title
Metabolic syndrome
Description
Blood pressure
Time Frame
Follow-up at approximately 6 years corrected age
Title
Allergy
Description
Allergy questionnaire
Time Frame
Follow-up at approximately 6 years corrected age
Title
Allergy
Description
blood samples; Immunoglobulin E (IgE)
Time Frame
Follow-up at approximately 6 years corrected age
Title
Allergy
Description
Lung function: NO-test
Time Frame
Follow-up at approximately 6 years corrected age

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participated in the original study when they were discharge from hospital Parents accept of participation in the 6 year follow-up Exclusion Criteria: Participation not accepted by parents Genetic diseases with influence on growth
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gitte Zachariassen, Specialist
Organizational Affiliation
HC Anderson Children´s Hospital, OUH, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Susanne Halken, Professor
Organizational Affiliation
HC Anderson children´s Hospital, OUH, Denmark
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Lone Agertoft, Specialist
Organizational Affiliation
HC Anderson children´s Hospital, OUH, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Line H Toftlund, MD
Organizational Affiliation
HC Anderson children´s Hospital, OUH, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
HC Anderson Children´s Hospital, OUH
City
Odense
ZIP/Postal Code
5000
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
9680492
Citation
Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998 Aug;95(2):115-28.
Results Reference
background
PubMed Identifier
15135796
Citation
Hofman PL, Regan F, Harris M, Robinson E, Jackson W, Cutfield WS. The metabolic consequences of prematurity. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S136-9. doi: 10.1016/j.ghir.2004.03.029.
Results Reference
background
PubMed Identifier
19881394
Citation
Amesz EM, Schaafsma A, Cranendonk A, Lafeber HN. Optimal growth and lower fat mass in preterm infants fed a protein-enriched postdischarge formula. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):200-7. doi: 10.1097/MPG.0b013e3181a8150d.
Results Reference
background
PubMed Identifier
15548778
Citation
Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med. 2004 Nov 18;351(21):2179-86. doi: 10.1056/NEJMoa042275. Erratum In: N Engl J Med. 2004 Dec 30;351(27):2888.
Results Reference
background
PubMed Identifier
14679488
Citation
Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004 Jan;37(1):43-9. doi: 10.1002/ppul.10402.
Results Reference
background
PubMed Identifier
17379288
Citation
Liem JJ, Kozyrskyj AL, Huq SI, Becker AB. The risk of developing food allergy in premature or low-birth-weight children. J Allergy Clin Immunol. 2007 May;119(5):1203-9. doi: 10.1016/j.jaci.2006.12.671. Epub 2007 Mar 26.
Results Reference
background
Citation
G. Zachariassen, J Færk mf. Nutrient-enrichment of human milk for preterm infants after hospital discharge - a randomized controlled trial. Pediatrics 2010.
Results Reference
background
PubMed Identifier
18381542
Citation
O'Connor DL, Khan S, Weishuhn K, Vaughan J, Jefferies A, Campbell DM, Asztalos E, Feldman M, Rovet J, Westall C, Whyte H; Postdischarge Feeding Study Group. Growth and nutrient intakes of human milk-fed preterm infants provided with extra energy and nutrients after hospital discharge. Pediatrics. 2008 Apr;121(4):766-76. doi: 10.1542/peds.2007-0054.
Results Reference
background
PubMed Identifier
12837903
Citation
Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003 Jul;112(1 Pt 1):e30-8. doi: 10.1542/peds.112.1.e30.
Results Reference
background
PubMed Identifier
17079546
Citation
Farooqi A, Hagglof B, Sedin G, Gothefors L, Serenius F. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study. Pediatrics. 2006 Nov;118(5):e1452-65. doi: 10.1542/peds.2006-1069.
Results Reference
background
PubMed Identifier
12242586
Citation
De Curtis M, Pieltain C, Rigo J. Body composition in preterm infants fed standard term or enriched formula after hospital discharge. Eur J Nutr. 2002 Aug;41(4):177-82. doi: 10.1007/s00394-002-0374-2.
Results Reference
background
PubMed Identifier
21402642
Citation
Zachariassen G, Faerk J, Grytter C, Esberg BH, Hjelmborg J, Mortensen S, Thybo Christesen H, Halken S. Nutrient enrichment of mother's milk and growth of very preterm infants after hospital discharge. Pediatrics. 2011 Apr;127(4):e995-e1003. doi: 10.1542/peds.2010-0723. Epub 2011 Mar 14.
Results Reference
background
PubMed Identifier
21332800
Citation
Zachariassen G, Faerk J, Esberg BH, Fenger-Gron J, Mortensen S, Christesen HT, Halken S. Allergic diseases among very preterm infants according to nutrition after hospital discharge. Pediatr Allergy Immunol. 2011 Aug;22(5):515-20. doi: 10.1111/j.1399-3038.2010.01102.x. Epub 2011 Feb 20.
Results Reference
background
PubMed Identifier
29722837
Citation
Toftlund LH, Halken S, Agertoft L, Zachariassen G. Early nutrition and signs of metabolic syndrome at 6 y of age in children born very preterm. Am J Clin Nutr. 2018 May 1;107(5):717-724. doi: 10.1093/ajcn/nqy015. Erratum In: Am J Clin Nutr. 2019 Aug 1;110(2):530-531.
Results Reference
derived

Learn more about this trial

Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition

We'll reach out to this number within 24 hrs